skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Table of Contents

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

Appendix A: Key to Acronyms

Drug Name Abbreviations

(Last updated: July 14, 2016; last reviewed: July 14, 2016)

Drug Name Abbreviations
Abbreviation Full Name
3TC lamivudine
ABC
abacavir 
APV amprenavir
ATV atazanavir 
ATV/c  
atazanavir/cobicistat
ATV/r
atazanavir/ritonavir 
COBI or c
cobicistat 
d4T
stavudine 
DCV daclatasvir
ddC
zalcitabine 
ddI
didanosine 
DLV
delavirdine 
DRV
darunavir 
DRV/c  
darunavir/cobicistat
DRV/r
darunavir/ritonavir 
DTG
dolutegravir 
EFV
efavirenz 
EFV/TDF/FTC  
efavirenz/tenofovir disoproxil fumarate/emtricitabine
ETR
etravirine 
EVG
elvitegravir 
EVG/c  
elvitegravir/cobicistat
EVG/c/TAF/FTC elvitegravir/cobicistat/tenofovir alafenamide/emtricitabine
EVG/c/TDF/FTC
elvitegravir/cobicistat/tenofovir disoproxil fumarate/emtricitabine 
EVG/r  
elvitegravir/ritonavir
FPV
fosamprenavir 
FPV/r  
fosamprenavir/ritonavir 
FTC
emtricitabine 
IDV
indinavir 
IDV/r indinavir/ritonavir
LPV
lopinavir 
LPV/r  
lopinavir/ritonavir
MVC
maraviroc 
NFV
nelfinavir 
NVP
nevirapine 
PI/c
cobicistat-boosted protease inhibitor 
PI/r
ritonavir-boosted protease inhibitor 
RAL  
raltegravir
RPV
rilpivirine 
RTV
ritonavir 
SQV
saquinavir 
SQV/r
saquinavir/ritonavir 
T-20 enfuvirtide
TAF tenofovir alafenamide
TDF
tenofovir disoproxil fumarate
TPV
tipranavir 
TPV/r
tipranavir/ritonavir 
ZDV zidovudine

Back to Top